In this interview, Valerie Bandy, vice president of Pharmacy Solutions, Tecsys, discusses the complex operational realities ...

Vice President Pharmacy Solutions at Tecsys. With a career marked by this steadfast leadership, she has consistently excelled ...

More than $21 billion of Lilly’s domestic manufacturing commitments this decade have been directed to Indiana.¹ The Lebanon ...

Looking at the wider industry landscape, Sanderson acknowledges the extraordinary level of activity currently reshaping the ...

Dirk Schuster is sales director Pharma at groninger & co. GmbH as well as a member of the company’s management board. He is responsible for global sales activities in the pharmaceutical sector, with a ...

Analytical characterization is vital for product quality, manufacturing control, and regulatory compliance in biopharmaceutical development. ICH Q6B outlines structural characterization requirements, ...

As a critical raw material for our manufacturing operations, media and buffers sit at the heart of the supply chain. On the ...

Maria Batalha, Valgenesis, discusses how a centralized digital platform unified drug substance data from R&D to commercial ...

Intensified regulator focus is pushing sterile operations away from personnel manipulations, elevating robotics from optional ...

The authors provide their perspectives on shipping validation. As the biotech industry evolves, there are mounting concerns about the transportation, security, and robustness of cell-culture media, ...

Virtual control groups, automation, novel excipients, and sustainability are some of the topics covered by PharmTech this ...

EMA encourages NAMs to replace animal testing, aligning with 3Rs principles, and has published a concept paper on regulatory acceptance. EFPIA supports phasing out animal testing, emphasizing ...